## LULU: lululemon athletica inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.90 indicates fundamental undervaluation. Quality metrics strong (ROE 42%, ROA 22%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-3.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($174.71)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Lululemon (LULU) Q3 Earnings: What To Expect**
- Source: Finviz | 20251210T032846 | Neutral | Relevance: 99%
-  Lululemon (LULU) will report its Q3 earnings this Thursday afternoon, with analysts expecting a 3.3% year-on-year revenue growth to $2.48 billion and adjusted earnings of $2.21 per share. The company missed revenue expectations last quarter, and its full-year EPS guidance fell short of analyst estimates. Competitors like Zumiez and American Eagle have shown positive Q3 results, and investor sentiment in the apparel retailer sector is currently positive.

**2. Lululemon CEO Calvin McDonald to step down amid languishing sales in the US**
- Source: ABC News | 20251212T001533 | Neutral | Relevance: 99%
-  Lululemon CEO Calvin McDonald is stepping down effective January 31, 2026, as the company faces a year of disappointing sales, particularly in the U.S. Marti Morfitt will serve as executive chair, and Meghan Frank and André Maestrini will be interim co-CEOs while a successor is sought. This leadership change comes amidst challenges like a weakened athleisure market, increased competition, and criticism from the company's founder.

**3. Lululemon CEO to step down in January**
- Source: The Globe and Mail | 20251211T212730 | Neutral | Relevance: 99%
- Lululemon Athletica Inc. CEO Calvin McDonald will step down from his role on January 31, 2026, and also leave the company's board, transitioning to a senior adviser role. This announcement comes after a period of significant stock price decline and criticism from the company's founder. CFO Meghan Frank and CCO André Maestrini will serve as interim co-CEOs while an executive search firm looks for a new leader to drive growth and transformation.

**4. Federated Hermes Inc. Purchases 99,664 Shares of lululemon athletica inc. $LULU**
- Source: MarketBeat | 20251210T140815 | Neutral | Relevance: 99%
- Federated Hermes Inc. significantly increased its stake in lululemon athletica inc. (NASDAQ:LULU) during the second quarter, purchasing an additional 99,664 shares to bring its total holdings to 104,980 shares, valued at approximately $24.94 million. This move represents an 1,874.8% boost in their position in the apparel retailer. The article also provides details on other institutional investor activities, insider transactions, recent analyst ratings, and key financial metrics for lululemon.

**5. Lululemon Chief Executive Calvin McDonald to Depart Next Month**
- Source: The Wall Street Journal | 20251211T220933 | Neutral | Relevance: 98%
-  Lululemon Athletica CEO Calvin McDonald will step down in January and relinquish his board seat, though he will remain a senior adviser through March to ensure a smooth transition. This departure comes amidst pressure from the company's founder, Chip Wilson, who was reportedly preparing for a proxy fight to instigate changes following a significant decline in Lululemon's share value.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Guggenheim | $0 | $0 | 0% |
| 2025-12-08 | Telsey Advisory | $200 | $200 | 0% |
| 2025-11-25 | BTIG | $303 | $303 | 0% |
| 2025-11-18 | Goldman Sachs | $180 | $200 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Guggenheim | init | Neutral |
| 2025-12-08 | Telsey Advisory | main | Market Perform |
| 2025-11-25 | BTIG | reit | Buy |
| 2025-11-18 | Goldman Sachs | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+3.9%)
- Blackrock Inc.: 8.8% (-0.9%)
- State Street Corpora: 4.1% (-1.1%)
- FMR, LLC: 3.6% (-65.8%)
- Geode Capital Manage: 2.6% (+0.6%)

### Key Risks

1. Elevated short interest (8.8%): bears positioning against stock.
2. Long-term trend broken: trading 19.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 14.4x stretched relative to 1% growth. Quality metrics strong (ROE 42%, ROA 22%, margin 16%). Balance sheet: strong liquidity (2.3x). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.4B |
| Beta | 1.01 |
| 52W Range | $159.25 - $423.32 |
| Short Interest | 8.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 14.4 |
| Current P/E | 14.5 |
| YoY Growth | 0.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.8% to 3.4% (-3.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.6pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. AM_20 at 5.6% shows strong absolute momentum above own 20MA. Below SMA200 (0.81x), long-term trend not supportive. MACD histogram positive (1.07), confirming momentum. Elevated volume (1.4x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.44% (CS: 68) | Neutral |
| RSI_14 | 61.5 | Neutral |
| MACD Histogram | 1.07 | Bullish |
| vs SMA20 | 1.056x | Above |
| vs SMA50 | 1.076x | Above |
| vs SMA200 | 0.806x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $187.01
- **Stop Loss:** $174.71 (6.6% risk)
- **Target:** $211.61 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 112
- **Position Value:** $20,945.12
- **Portfolio %:** 20.95%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.85 | $3.10 | +8.7% |
| 2025Q2 | $2.59 | $2.60 | +0.4% |
| 2025Q1 | $5.87 | $6.14 | +4.6% |
| 2024Q4 | $2.72 | $2.87 | +5.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*